ZA938825B - Pharmaceutical compositions - Google Patents
Pharmaceutical compositionsInfo
- Publication number
- ZA938825B ZA938825B ZA938825A ZA938825A ZA938825B ZA 938825 B ZA938825 B ZA 938825B ZA 938825 A ZA938825 A ZA 938825A ZA 938825 A ZA938825 A ZA 938825A ZA 938825 B ZA938825 B ZA 938825B
- Authority
- ZA
- South Africa
- Prior art keywords
- pharmaceutical compositions
- pharmaceutical
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929224855A GB9224855D0 (en) | 1992-11-27 | 1992-11-27 | Pharmaceutical compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA938825B true ZA938825B (en) | 1995-05-25 |
Family
ID=10725759
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA938825A ZA938825B (en) | 1992-11-27 | 1993-11-25 | Pharmaceutical compositions |
Country Status (10)
Country | Link |
---|---|
US (1) | US5597844A (xx) |
EP (1) | EP0670722A1 (xx) |
JP (1) | JPH08503482A (xx) |
KR (1) | KR950703952A (xx) |
CN (1) | CN1095923A (xx) |
AU (1) | AU5563494A (xx) |
CA (1) | CA2149884A1 (xx) |
GB (1) | GB9224855D0 (xx) |
WO (1) | WO1994012180A1 (xx) |
ZA (1) | ZA938825B (xx) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU7218194A (en) * | 1993-07-06 | 1995-02-06 | Mcneil-Ppc, Inc. | H2 antagonist-alginate-antacid combinations |
US5808090A (en) * | 1996-02-22 | 1998-09-15 | Endo Pharmaceuticals Inc. | Process for preventing precipitation in cimetidine injection solutions |
US8071128B2 (en) | 1996-06-14 | 2011-12-06 | Kyowa Hakko Kirin Co., Ltd. | Intrabuccally rapidly disintegrating tablet and a production method of the tablets |
CN1154479C (zh) * | 1996-06-14 | 2004-06-23 | 协和发酵工业株式会社 | 口腔内快速崩解片剂 |
FR2753904B1 (fr) * | 1996-10-01 | 1998-10-30 | Gattefosse Ets Sa | Composition pharmaceutique a liberation modifiee de principe actif, comportant une matrice, et procede de fabrication |
EP1364584B1 (en) * | 1997-08-14 | 2005-10-26 | Cadbury Adams USA LLC | Taste modified hard confectionery compositions containing functional ingredients |
US6242019B1 (en) * | 1997-08-14 | 2001-06-05 | Warner-Lambert Company | Taste modified hard confectionery compositions containing functional ingredients |
IN186245B (xx) * | 1997-09-19 | 2001-07-14 | Ranbaxy Lab Ltd | |
AU9496798A (en) | 1997-09-19 | 1999-04-05 | Shire Laboratories, Inc. | Solid solution beadlet |
US5891476A (en) * | 1997-12-22 | 1999-04-06 | Reo; Joe P. | Tastemasked pharmaceutical system |
WO1999033445A1 (en) * | 1997-12-29 | 1999-07-08 | The Procter & Gamble Company | Tablet composition |
UA65607C2 (uk) * | 1998-03-04 | 2004-04-15 | Орто-Макнейл Фармацевтикал, Інк. | Фармацевтична композиція (варіанти) та спосіб її приготування |
FR2779651B1 (fr) * | 1998-06-16 | 2001-04-20 | Gattefosse Ets Sa | Procede pour la fabrication de comprimes a liberation prolongee de principe(s) actif(s) presentant une cinetique de dissolution d'ordre zero |
BR9912533A (pt) * | 1998-07-31 | 2002-02-13 | Otsuka Pharma Co Ltd | Composição farmacêutica tendo sabor melhorado |
FR2784895B1 (fr) * | 1998-10-23 | 2004-12-17 | Gattefosse Ets Sa | Comprime a croquer a gout masque et liberation immediate du principe actif et procede de fabrication |
US6794411B1 (en) | 1999-04-06 | 2004-09-21 | Laboratoire Des Produits Ethiques Ethypharm | Drinkable ibuprofen pharmaceutical suspension |
US8895064B2 (en) | 1999-06-14 | 2014-11-25 | Cosmo Technologies Limited | Controlled release and taste masking oral pharmaceutical composition |
PT1183014E (pt) | 1999-06-14 | 2003-12-31 | Cosmo Spa | Composicoes farmaceuticas orais de libertacao controlada e de dissimulacao de sabor |
US9358214B2 (en) | 2001-10-04 | 2016-06-07 | Adare Pharmaceuticals, Inc. | Timed, sustained release systems for propranolol |
GB2398221B (en) * | 2001-10-26 | 2006-04-12 | John Kohnke | Dosage system & dosage vehicle therefor |
AUPS244002A0 (en) | 2002-05-20 | 2002-06-13 | John Kohnke Products Pty Ltd | Agent delivery system |
US8367111B2 (en) | 2002-12-31 | 2013-02-05 | Aptalis Pharmatech, Inc. | Extended release dosage forms of propranolol hydrochloride |
AU2004294813A1 (en) * | 2003-12-04 | 2005-06-16 | Pfizer Products Inc. | Spray-congeal process using an extruder for preparing multiparticulate azithromycin compositions containing preferably a poloxamer and a glyceride |
WO2005053655A1 (en) * | 2003-12-04 | 2005-06-16 | Pfizer Products Inc. | Method for making pharmaceutical multiparticulates |
WO2005053652A1 (en) | 2003-12-04 | 2005-06-16 | Pfizer Products Inc. | Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride |
BRPI0417348A (pt) * | 2003-12-04 | 2007-03-13 | Pfizer Prod Inc | processo de gelatinização por spray com utilização de uma extrusora para preparação de composições de droga cristalina multiparticulada contendo preferencialmente um poloxámero e um glicerìdeo |
US6984403B2 (en) * | 2003-12-04 | 2006-01-10 | Pfizer Inc. | Azithromycin dosage forms with reduced side effects |
CN1889933A (zh) * | 2003-12-04 | 2007-01-03 | 辉瑞产品公司 | 由基于液体的工艺制备的阿奇霉素多颗粒剂型 |
WO2005053639A2 (en) * | 2003-12-04 | 2005-06-16 | Pfizer Products Inc. | Controlled release multiparticulates formed with dissolution enhancers |
WO2005053651A1 (en) * | 2003-12-04 | 2005-06-16 | Pfizer Products Inc. | Multiparticulate compositions with improved stability |
US8747895B2 (en) | 2004-09-13 | 2014-06-10 | Aptalis Pharmatech, Inc. | Orally disintegrating tablets of atomoxetine |
US9884014B2 (en) | 2004-10-12 | 2018-02-06 | Adare Pharmaceuticals, Inc. | Taste-masked pharmaceutical compositions |
MX2007004741A (es) | 2004-10-21 | 2007-09-07 | Eurand Pharmaceuticals Ltd | Composiciones farmaceuticas con sabor enmascarado con formadores de poro gastrosolubles. |
US9161918B2 (en) | 2005-05-02 | 2015-10-20 | Adare Pharmaceuticals, Inc. | Timed, pulsatile release systems |
GB0515492D0 (en) * | 2005-07-28 | 2005-08-31 | Reckitt Benckiser Healthcare | Improvements in or relating to compositions,articles and methods |
DE102006037298A1 (de) | 2006-08-08 | 2008-02-14 | Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh | Pharmazeutische Zusammensetzung, insbesondere Antazidum |
EP2506836B1 (en) | 2009-12-02 | 2018-02-14 | Adare Pharmaceuticals S.R.L. | Fexofenadine microcapsules and compositions containing them |
BR112013008834B1 (pt) * | 2010-10-12 | 2021-08-03 | Bayer Intellectual Property Gmbh | Produto mastigável macio e seu processo de preparação |
US10154964B2 (en) | 2011-09-07 | 2018-12-18 | Cosmo Technologies Limited | Controlled release and taste masking oral pharmaceutical composition |
JP6039042B1 (ja) | 2015-11-20 | 2016-12-07 | 株式会社スクウェア・エニックス | 描画処理プログラム、描画処理装置、描画処理方法、発音処理プログラム、発音処理装置、及び、発音処理方法 |
AU2017345473A1 (en) * | 2016-10-19 | 2019-04-18 | Signpath Pharma, Inc. | Protective effect of DMPC, DMPG, DMPC/DMPG, LysoPG and LysoPC against drugs that cause channelopathies |
CN109890368B (zh) * | 2016-11-01 | 2021-12-21 | 强生消费者公司 | 包含组胺h2受体拮抗剂和抗酸剂的液体口服药物剂型 |
US20180140630A1 (en) * | 2016-11-23 | 2018-05-24 | M. Michael Wolfe | Combination of an h2-receptor antagonist, antacid, and alginic acid to treat episodic heartburn |
IT201800002625A1 (it) | 2018-02-13 | 2019-08-13 | Drugs Minerals And Generics Italia S R L In Forma Abbreviata D M G Italia S R L | Composizione in forma solida per uso nel trattamento dei sintomi extra-esofagei del reflusso gastrico |
CN112822998A (zh) * | 2018-10-18 | 2021-05-18 | 强生消费者公司 | 新型剂型 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR960011236B1 (ko) * | 1987-05-08 | 1996-08-21 | 스미스 클라인 앤드 프렌취 라보라토리스 리미티드 | 제약학적 조성물 및 고체 제형 |
GB8730011D0 (en) * | 1987-12-23 | 1988-02-03 | Smithkline Dauelsberg | Pharmaceutical compositions |
AU8546591A (en) * | 1990-09-13 | 1992-04-15 | Smithkline Beecham Corporation | Non-aqueous liquid oral suspensions |
EP0587744B1 (en) * | 1991-05-28 | 2003-07-16 | McNEIL-PPC, Inc. | Chewable drug-delivery composition |
US5229137A (en) * | 1992-05-06 | 1993-07-20 | Brigham And Women's Hospital, Inc. | Methods and pharmaceutical compositions for treating episodic heartburn |
-
1992
- 1992-11-27 GB GB929224855A patent/GB9224855D0/en active Pending
-
1993
- 1993-11-22 JP JP6512741A patent/JPH08503482A/ja active Pending
- 1993-11-22 EP EP94900825A patent/EP0670722A1/en not_active Withdrawn
- 1993-11-22 CA CA002149884A patent/CA2149884A1/en not_active Abandoned
- 1993-11-22 AU AU55634/94A patent/AU5563494A/en not_active Abandoned
- 1993-11-22 KR KR1019950702123A patent/KR950703952A/ko not_active Application Discontinuation
- 1993-11-22 US US08/446,708 patent/US5597844A/en not_active Expired - Fee Related
- 1993-11-22 WO PCT/EP1993/003272 patent/WO1994012180A1/en not_active Application Discontinuation
- 1993-11-25 ZA ZA938825A patent/ZA938825B/xx unknown
- 1993-11-26 CN CN93120534A patent/CN1095923A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
JPH08503482A (ja) | 1996-04-16 |
US5597844A (en) | 1997-01-28 |
KR950703952A (ko) | 1995-11-17 |
GB9224855D0 (en) | 1993-01-13 |
CA2149884A1 (en) | 1994-06-09 |
WO1994012180A1 (en) | 1994-06-09 |
CN1095923A (zh) | 1994-12-07 |
EP0670722A1 (en) | 1995-09-13 |
AU5563494A (en) | 1994-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9224855D0 (en) | Pharmaceutical compositions | |
GB9308014D0 (en) | Pharmaceutical compositions | |
HUT66864A (en) | Pharmaceutical compositions | |
GB9319500D0 (en) | Pharmaceutical composition | |
GB2272375B (en) | Pharmaceutical composition | |
GB9209874D0 (en) | Pharmaceutical compositions | |
GB9221707D0 (en) | Pharmaceutical composition | |
ZA935078B (en) | Pharmaceutical composition | |
ZA94155B (en) | Pharmaceutical composition | |
GB9226377D0 (en) | Pharmaceutical compositions | |
GB9211276D0 (en) | Pharmaceutical compositions | |
ZA924061B (en) | Pharmaceutical composition | |
ZA935931B (en) | Pharmaceutical composition | |
ZA931984B (en) | Pharmaceutical composition | |
GB9222941D0 (en) | Pharmaceutical compositions | |
GB9221800D0 (en) | Pharmaceutical compositions | |
IL102579A0 (en) | Pharmaceutical compositions | |
ZA935161B (en) | Pharmaceutical compositions | |
GB9222942D0 (en) | Pharmaceutical compositions | |
GB9203500D0 (en) | Pharmaceutical compositions | |
GB9206412D0 (en) | Pharmaceutical compositions | |
ZA925331B (en) | Pharmaceutical compositions | |
GB9210226D0 (en) | Pharmaceutical compositions | |
GB9211400D0 (en) | Pharmaceutical compositions | |
GB9221447D0 (en) | Pharmaceutical compositions |